- HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
- HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
- HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
- HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
- HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
- HilleVax to Present at Upcoming Investor Conferences
- HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
- HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- HilleVax Announces Pricing of Public Offering of Common Stock
More ▼
Key statistics
On Wednesday, Hillevax Inc (HLVX:NSQ) closed at 12.58, 26.56% above the 52 week low of 9.94 set on Oct 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.69 |
---|---|
High | 12.84 |
Low | 12.47 |
Bid | 5.02 |
Offer | 13.36 |
Previous close | 12.81 |
Average volume | 214.29k |
---|---|
Shares outstanding | 49.70m |
Free float | 46.03m |
P/E (TTM) | -- |
Market cap | 636.67m USD |
EPS (TTM) | -3.04 USD |
Data delayed at least 15 minutes, as of Apr 24 2024 21:00 BST.
More ▼